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ATRIAL NATRIURETIC 
PEPTIDE RELEASE AT 
REST AND WITH EXERCISE 
AFTER CARDIAC 
TRANSPLANTATION WITH 
BICAVAL ANASTOMOSES 
Bicaval anastomoses in orthotopic cardiac transplantation offer the advan- 
tage of preserving the right atrial geometry. To elucidate the impact of this 
anastomotic technique on atrial natriuretic peptide plasma levels at rest 
and with exercise, nine patients were submitted to a symptom-limited 
supine exercise test. Atrial natriuretic peptide plasma levels in samples 
obtained from the right atrium were elevated at rest (274.4 _ 60.4 pg/ml), 
at peak exercise (438.1 -- 71.7 pg/ml), and thereafter (328.1 -- 71.2 pg/ml) 
with respect o normal reference values of 21 -- 1 pg/ml at rest and 92 + 14 
at peak exercise. Renin, angiotensin, and aldosterone plasma levels were 
almost normal and did not indicate any pathologic processes in volume 
homeoostasis. Right-sided hemodynamic parameters were not correlated 
with atrial natriuretic peptide secretion. An adverse relationship between 
cold ischemic time of the donor organ and atrial natriuretic peptide release 
was found (r = 0.88, p < 0.0008), indicating that endocrine cardiocytes are 
sensitive to prolonged ischemia. Atrial natriuretic peptide release may thus 
be independent of the surgical approach, and other unique characteristics 
of the transplanted heart, such as denervation, are more likely to be 
responsible for elevated atrial natriuretic peptide plasma concentrations 
after orthotopic heart transplantation. (J THORAC CARDIOVASC SURG 1995; 
110:1600-5) 
Andres W. Jahnke, MD,* Rainer Leyh, MD,* Alexander Bernhard, PhD, and 
Hans H. Sievers, PhD,* Kiel, Germany 
A trial natriuretic peptide (ANP) is an important determinant in fluid and electrolyte homeostasis, 
regulating blood pressure and intravascular volume 
as a functional antagonist to vasopressin and the 
renin-angiotensin-aldosterone syst m. 1 ANP is syn- 
thesized and secreted by atrial cardiocytes, which 
are more frequent i  the right atrium than in the left 
and are most abundant in the atrial appendage) 
Excessive ANP plasma levels have been reported in 
patients with heart failure and also after standard 
cardiac transplantation. 1'3-s The stimulus for the 
disproportionate increase in plasma ANP level 
could be the elevated myocardial transmural pres- 
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sure caused by the altered atrial anatomy and con- 
comitantly changed hemodynamics a sociated with 
the composite right atrium. 1' 6.9 This standard tech- 
nique, originally described by Lower and Shum- 
way, 1° comprises two atrial anastomoses, with a 
subsequent tissue increase of approximately 25% of 
the composite right atrium s and a larger than nor- 
mal atrial diameter. 11 In a previous study, 11 we 
showed that bicaval anastomoses in heart ransplan- 
tation, first introduced into clinical practice in 
1989,12 can normalize right atrial dimension com- 
pared with the conventional technique. The entire 
group from that study is included in this report. 
Bicaval anastomoses in cardiac transplantation pro- 
vide a unique model of a normally configured right 
atrium with less secretory atrial tissue. Study of 
cardiac transplant recipients with bicaval instead 
of right atrial anastomoses may allow elucidation of 
the impact of the surgical approach on ANP plasma 
levels after cardiac transplantation. 
Methods 
Patients. Nine consecutive patients with bicaval anas- 
tomoses were submitted to a graded, symptom-limited 
supine exercise test after routine endomyocardial biopsy 
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(EMB). The patients had been previously operated on 
according to a randomized protocol. Informed consent 
was obtained before the study from every patient. Demo- 
graphic data of the studied subjects are depicted in Table 
I. The patients were free of rejection, as proved by EMB, 
and without clinical signs of congestive heart failure. 
All cardiac transplant recipients received a conventional 
triple-drug therapy consisting of cyclosporine (adjusted to 
a whole blood level of 250 to 300 ng/ml), azathioprine (1 
to 2 mg/kg per day), and prednisone (0.2 mg/kg per day). 
Standard induction therapy with anti-T-lymphocyte glob- 
ulin was done for 4 days. Prednisone was withdrawn as 
early as clinically possible. 
Operative technique. The technique of bicaval anasto- 
moses has been described in detail elsewhere] 2 In brief, 
the recipient is cannulated with separate caval cannulas as 
distally as possible with standard cardiopulmonary b pass 
and hypothermia of approximately 24 ° C. The heart is 
excised, leaving a 10 mm atrial cuff at the inferior vena 
cava and preserving the whole superior vena cava. Trim- 
ming is performed with respect o the donor heart size. 
Concerning the left atrium, only a small cuff combining 
the pulmonary venous ostia is left in place. The left 
atrial anastomosis done with a continuous intralumi- 
nal suture of 3-0 Prolene (Ethicon, Inc., Somerville, 
N.J.). The superior vena cava is sutured with 5-0 
Prolene interrupted sutures, and the inferior vena cava 
is anastomosed with a 4-0 Prolene running suture. The 
arterial anastomoses are performed conventionally with 
3-0 Prolene sutures. 
Exercise protocol and collection of blood samples. 
There was at least 1 hour of rest between EMB and the 
exercise testing on a supine exercise unit (Siemens 870 L; 
Siemens ag-Medizinische Technik, Hamburg, Ger- 
many). Workload was increased stepwise very 5 minutes 
by 25 W until either cardiopulmonary or physical exhaus- 
tion. Blood samples for hormone assays were obtained 
through a triple-lumen thermodilution pulmonary arterial 
catheter, which was inserted immediately after EMB. 
Blood samples were drawn from the right atrium at rest, at 
individual peak exercise, and 10 minutes later. They were 
collected in chilled tubes containing 10 mg ethylenedia- 
minetetraacetic a id and were stored immediately on dry 
ice. After completion of the exercise test, the blood samples 
were centrifuged at 4 ° C for 20 minutes at 2600 rpm. The 
supernatmlt was stored at -80  ° C until hormone assay was 
done, according to the manufacturers' manual (Nichols 
Institute Diagnostics B.V., Wijchen, The Netherlands). He- 
modynamic parameters were measured at each step in 
triplicate by the use of a Baxter REF 1 thermodilution 
computer (Baxter Healthcare Corp., Edwards Critical Care, 
Irvine, Calif.). The mean of three measurements was com- 
puted and used for subsequent evaluation. 
Hormone assays 
ANP. ANP was measured by a direct radioimmunoas- 
say for human ANP (Nichols Institute Diagnostics). Free 
and bound hormone were separated by antibody-polyeth- 
ylene glycol separation and centrifugation. After decanta- 
tion of the supernatant, the pellet containing the bound 
fraction was counted. Quantitation was achieved by de- 
layed addition of the iodinated tracer. Concentrations are 
expressed in picograms per milliliter after correction for 
Table I. Patient characteristics 
Bicaval 
(n = 9) 
Age (yr) 43.6 ± 5.9 
Height (cm) 180.2 ± 2.4 
Weight (kg) 89.0 _+ 5.0 
Interval (too)* 28.0 ± 4.6 
Donor age (yr) 41.4 _+ 5.8 
Cold ischemic time (hr) 2.66 _+ 0.29 
Duration of heart failure (too)? 25.0 ± 7.8 
Cyclosporine blood level (ng/ml) 260 _+ 66 
Creatinine blood level (mg/dl) 1.5 ± 0.2 
*Between heart transplantation and study. 
+Before transplantation. 
dilution. The normal reference value for ANP at rest is 
21 _+ 1 pg/ml, as established in a recently published study. 3
The reference value for ANP secretion at exercise is 92 _+ 
14 pg/ml, established in the same study. 3 To our knowl- 
edge, there is no standard for postexercise ANP plasma 
level in healthy subjects. 
Hormone levels were measured to exclude any influ- 
ence on ANP levels resulting from disorders in the 
hormonal subsystems of the fluid homeostasis. 
Antidiuretic hormone (Vasopressin). Arginine-vasopressin 
was measured with a double radioimmunoassay (Vaso- 
pressin Rapid RIA, RK-AR1, Bfihlmann Labaratories 
Ltd., Schoenenbuch, Switzerland) by means of a modified 
method previously described by Glick and Kagan. 13 
Plasma samples were extracted with ethanol. Values rang- 
ing from 0.8 to 6 pg/ml were considered normal. 
Renin. Plasma renin concentration was measured with 
a commercially available radioimmunoassay detecting the 
active renin (Renin-IRMA Pasteur; Laboserv gmbh Diag- 
nostica, GieBen, Germany). Supine normal values range 
from 10 to 30 pg/ml. 
Aldosterone. Plasma aldosterone was measured by the 
use of a radioimmunoassay without previous extraction. 
This was achieved according to the concept of solid-phase 
specific antibody binding (Aldosterone-RIA, solid-phase 
radioimmunoassay, DPC; Biermann Diagnostics, Bad 
Nauheim, Germany). Supine normal values range from 12 
to 125 pg/ml. 
Statistical analysis. All values are expressed as the 
mean plus or minus the standard error of the mean, as an 
index of dispersion, unless otherwise specified. Linear 
regression was applied to determine the relationships 
between ANP plasma level and hemodynamic parameters. 
Statistical significance was analyzed with the Behrens- 
Fisher t test after evaluation of normal distribution ac- 
cording to the method of David. 14 A probability value less 
than 0.05 was considered significant. 
Results 
Patient characteristics and work performance. 
Demographic  data and the work per formance of the 
studied subjects is compi led in Table I. The mean 
work load was 100 ± 33 W. Renal  function, as 
reflected by creatinine blood level, and cyclosporine 
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Table II. Hormonal response at rest, at peak 
exercise, and after exercise 
Bicaval 
(n = 9) Reference value (supine) 
ANP 
Rest 274 -+ 60.4 21 _+ 1 pg/ml (ref. 3)* 
Peak 438.1 + 71.1 92 ± 14 pg/ml (ref. 3)* 
After 338.1 + 71.2 
ADH 
Rest 2.99 -+ 0.73 0.8 pg/ml? 
Peak 2.55 + 0.67 6 pg/mlt 
After 3.91 + 0.82 
Renin 
Rest 20.44 + 2.84 10 pg/mlt 
Peak 25.78 + 5.1 30 pg/mlt 
After 23.44 + 3.86 
Aldosterone 
Rest 125.4 ± 22.4 70 pg/ml~ 
Peak 164.8 _+ 29.2 295 pg/mll 
After 148.1 + 34.1 
*Significant, with p < 0.05. 
tNot significant. 
whole blood level were unobtrusive, with no notice- 
able variation from our standard t ansplant patients. 
Hormonal response. The hormonal changes in 
blood obtained from the right atrium in response to 
exercise are presented in Table II. The mean ANP 
plasma level at rest was 274 + 60.4 pg/ml; this was 
significantly elevated compared with the normal 
reference value of 21 + 1 pg/ml (p < 0.05). 3 
Furthermore, we obtained a value of 438.1 +_ 71.7 
pg/ml at peak workload. This is significantly elevated 
compared with the reference value of 92 _+ 14 pg/ml 
in normal volunteers (p < 0.05). 3 After exercise, the 
ANP plasma level remained elevated at 338.1 _+ 71.2 
pg/ml. Because of a lack of normal reference values 
immediately after exercise, we compared this value 
with the normal standard of 21 +_ i pg/ml and found 
it to be significantly elevated (p < 0.05). Vasopres- 
sin, renin, and aldosterone l vels were in the normal 
range or only slightly elevated (Table II). 
Hemodynamic data. Complete hemodynamic data 
are illustrated in Table III. Right atrial pressure in- 
creased 2.1-fold, from 6.4 + 1.3 mm Hg at rest to 13.6 
+ 1.8 rnm Hg at exercise. After exercise, the right 
atrial pressure (8.2 _ 1.3 mm Hg) returned almost to 
the resting value. The mean pulmonary arterial pres- 
sure, on the other hand, increased from 14.1 _+ 1.5 mm 
Hg to 31.7 _+ 2.7 turn Hg at peak exercise, representing 
a 2.2-fold increase. However, cardiac output (6.1 +_ 0.5 
L/rain) rose only to 11.6 + 0.9 L/rain at peak exercise. 
The wedge pressure increased from 8.6 _ 1.3 mm Hg 
to 21.6 _+ 7.8 mm Hg at peak exercise. Pulmonary 
Table III. Hemodynamic parameters at rest, at 
peak exercise, and after exercise 
Bicaval 
Right atrial pressure (ram Hg) 
Rest 6.4 +_ 1.3 
Peak 13.6 _+ 1.8 
After 8.2 +- 1.3 
Mean pulmonary artery pressure (ram Hg) 
Rest 14.1 + 1.5 
Peak 31.7 _+ 2.7 
After 13.8 +_ 1.5 
Cardiac output (L/min) 
Rest 6.1 + 0.5 
Peak 11.6 _+ 0.9 
After 6.4 -+ 0.61 
Wedge pressure (ram Hg) 
Rest 8.6 + 1.3 
Peak 21.6 + 7.8 
After 8.1 + 1.1 
Pulmonary vein resistance (dyn . sec . cm-~) 
Rest 74.7 -+ 14.7 
Peak 84.7 _+ 10.4 
After 98.8 + 19.8 
vascular esistance was uniformly low at rest, at peak 
exercise, and after exercise (Table III). We did not 
observe significant correlations by linear regression 
between ANP plasma levels and hemodynamic vari- 
ables. An adverse correlation between cold ischemic 
time and ANP plasma levels obtained from the right 
atrium was found (Fig. 1). 
Discussion 
It is well established that ANP is predominantly 
synthesized and secreted by endocrine myocytes of 
the right atrium, 4' 5 but the mechanism of its release 
is still controversialJ 5 Although ANP is secreted as 
pro-ANP 1-98, its entire biologic activity is mediated 
by the metabolite o~-ANP, 15 which binds to cellular 
receptors identified in kidney, adrenal gland, endo- 
thelial cells, platelets, and brainJ' 16,17 The physio- 
logic effect of ANP is the diminution of blood 
pressure by stimulation of natriuresis, with conse- 
quent volume reduction. This is achieved by an 
attenuated renal vascular tone with consecutive 
increased glomerular filtration and reduced osmo- 
larity in the kidneyJ 8 Because renin secretion is 
inhibited, angiotensin and aldosterone plasma levels 
diminish, with a subsequent reduction of vascular 
tone in all vessels excluding the mesenteric vascular 
system. 19-22 A further known effect is the modula- 
tion of baroreceptor function, probably transmitted 
by central sympatholytics. 22'23 These physiologic 
effects are important but limited mechanisms in the 
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Fig. 1. Correlation between ANP levels obtained from the right atrium at rest and cold ischemic time of 
the donor organ. 
response to the failing heart. Consistently, signifi- 
cantly increased ANP plasma levels have been re- 
ported not only in patients with cardiac failure but 
also, surprisingly, after orthotopic heart transplan- 
tation.a, 6, 9 
ANP elevation after heart transplantation. The 
surgical approach itself has been addressed as one 
responsible factor for increased ANP plasma levels 
after transplantation. 1'6'9 Not only do the com- 
pound atria of donor and recipient show a cyclic 
torsion during the cardiac cycle, with increased 
transmural pressure, 24 they also result in atrial en- 
largement, as proved by echocardiography. 7' 11, ~2, 4 
A larger diameter may result in a higher transmural 
pressure, according to the law of Laplace, and thus 
be responsible for increased ANP secretion. A fur- 
ther important aspect may be the additional amount 
of atrial tissue associated with atrial anastomoses, s 
If ANP is reduced by right atrial appendectomy, as 
proven clinically in human beings 25 and experimen- 
tally in dogs, 26 it might be postulated that additional 
atrial tissue as an adjunct o altered atrial configu- 
ration increases ANP secretion after cardiac re- 
placement. Because we showed in a previous tudy 1~ 
that right atrial dimension is significantly reduced 
and normal after bicaval anastomoses, we believe 
that this patient population can serve as a model to 
study the impact of the surgical approach on ANP 
release after cardiac replacement. 
On the basis of these observations, we hypothe- 
sized that patients with bicaval anastomoses and 
subsequent reduced atrial dimensions and tissue 
would have normal ANP plasma levels. Our findings 
do not support his assumption, however; we found 
elevated ANP concentrations in the studied group 
compared with normal reference values, as depicted 
in Table lI (274 +_ 60.4 pg/ml versus 21 + 1 pg/ml, 
p < 0.05). The elevations of the ANP concentrations 
were comparable to those mentioned in patients 
after standard atrial heart transplantation. 1'3'6-s 
Furthermore, a comparison of these data with addi- 
tional data from patients with standard orthotopic 
heart transplantation (  = 5) who were also exam- 
ined in this study clearly shows that patients with 
bicaval anastomoses do not have decreased ANP 
release (274 + 60.4 pg/ml bicaval versus 226 + 69.2 
pg/ml atrial). The elevated ANP secretion after 
cardiac transplantation may therefore b  caused by 
a more complex multifactorial process rather than 
simply a larger atrial tissue dimension or mass. 
Despite the lack of significant correlations between 
right atrial filling pressures and ANP plasma levels 
in this study, an association between right heart 
afterload and ANP secretion may still be possible, as 
1 6 0 4 Jahnke et al. 
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other investigators have proposed. 1'6'9 It cannot, 
however, be deduced from our data and limited 
patient number. 
Total denervation and ANP release. This study 
gives clinical support to experimental findings in 
dogs 27 and rats 28 that totally denervated hearts are 
capable of excessive ANP secretion, because the use 
of bicaval anastomoses results in total denervation 
as a result of the total extirpation of the recipient's 
heart, in contrast to the standard technique in which 
innervated remnants of the right atrium remain. It 
has been proposed that the sympathetic system has 
a suppressive ffect on ANP synthesis and that 
sympathetic denervation thus increases ANP re- 
leases  A hypersensitivity of ANP-synthesizing cells 
to circulating catecholamines may be a further pos- 
Sible mechanism. 7 Taking these and our results into 
account, one is tempted to assume that the altered 
innervation of the transplanted heart may play the 
major role in increased ANP secretion after heart 
replacement. 
Cold isehemic time and ANP. Interestingly, a
moderate and adverse correlation (r = 0.88) be- 
tween ANP plasma level and cold ischemic time of 
the donor organ is evident (Fig. 1). Although we do 
not have a sufficient explanation at hand, this may 
indicate that ANP-secreting myocytes are sensitive 
to prolonged ischemic events. Further investigations 
including studies of myocardial contractile function 
are needed to elucidate the impact of ischemic time 
on different cardiac cell populations. 
Study limitations. The most important limitation 
is the small sample size. Our results have to be 
interpreted carefully and need further investigations 
with larger patient numbers to fully elucidate the 
impact of the anastomotic technique on ANP secre- 
tion. 
Conclusion. This study shows that the bicaval 
technique of cardiac transplantation, which, pre- 
serves the right atrial geometry, does not result in 
normal ANP release as long as 11.4 +_ 2.3 months 
after operation. Whether the marked and excessive 
increase of ANP is related to denervation or to 
ischemic time remains to be evaluated in a larger 
series of patients. 
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